期刊文献+

我院2010~2012年抗高血压药物应用分析

Utilization of Antihypertensive Drugs in Our Hospital from 2010 to 2012
下载PDF
导出
摘要 目的:评价我院抗高血压药物的应用特点及趋势.方法:对我院2010~2012年抗高血压药物的销售金额、用药频度(DDDs)及日均费用等进行统计、分析.结果:抗高血压药物销售金额、用药频度逐年上升,以钙拮抗药(CCB)、血管紧张素Ⅱ受体拮抗药(ARB)、血管紧张素转换酶抑制剂(ACEI)等为主,血管紧张素Ⅱ受体拮抗药用量逐年增加.结论:我院抗高血压药物品种繁多,临床应用广泛,用药基本合理. Objective: To investigate the feature and tendency of the application of antihypertensive drugs in our hospital. Methods: The utilization of antihypertensive drugs in our hospital from 2010 to 2012 was analyzed statistically in respect of the consumption sum,DDDs and average daily cost etc. Results: Over the 3 years, the consumption sum and DDDs of antihypertensive drugs used in our hospital were increasing,especially those of calcium antagonists(CCB),angiotensin Ⅱ receptor antagonist(ARB), angiotensin-converting enzyme inhibitors (ACEI), etc. The consumption of ARB blocking agents increased year by year. Conclusion: The antihypertensive drugs are characterized by complicated categorization, wide variety, and widespread clinical application, and the use of which in our hospital is basically rational.
出处 《中国药物评价》 2014年第1期35-38,共4页 Chinese Journal of Drug Evaluation
关键词 抗高血压药 用药金额 用药频度 日均费用 分析 Antihypertensive drugs Consumption sum DDDs DDC Analysis
  • 相关文献

参考文献5

二级参考文献22

  • 1邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1426
  • 2Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension : analysis of worldwide data[J]. Lancet,2005,365:217-223.
  • 3World Health Organization. The world health report 2002. Reducing risks, pro- moting healthy life[ M]. Geneva: World Health Organization. 2002.
  • 42007 ESH Guidelines for the Management of Hypeitension[J]. J Hypertens, 2007,25: 1105-1118.
  • 5Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004 [ J ]. Hyperten- sion ,2007,49:69-75.
  • 6Gradman AH, Basile JN, Barry L,et al. Combination therapy in hypertension [ J]. J Am Soc Hypertens,2010,4( 1 ) :42-50.
  • 7Stanton T, Reid JL. Commentary-fixed dose combination therapy in the treat- ment of hypertension[ J]. J Hum Hypertens,2002,16(2) :75-78.
  • 8George LB, Pantelis AS, Matthew RW. Renal outcomes with different fixed- dose combination therapies in patients with hypertension at high risk for cardio- vascular events (ACCOMPLISH) : a prespecified secondary analysis of a randomised controlled trial[ J ]. Lancet ,2010,375 : 1173-1181.
  • 9Neutel JM, Saunders E, Bakris GL, et al. The efficacy and safety of low- and high- dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: The INCLUSIVE Trial [J]. J Clin Hypertens,2005,7(10) :578-586.
  • 10Zappe D, Papst CC, Philippe F. Randomized study to compare valsartan ±HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control [J]. Vasc Health Risk Manag ,2009,5: 883-892.

共引文献4566

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部